Ellen Bergendahl, PharmD

Regenerative Medical Solutions (RMS) is a biotechnology company focused on transforming diabetes treatment through innovative stem cell technology. Based in Madison, WI, RMS specializes in developing stem cell-derived Islet-Like Clusters (ILCs) for both continued research purposes and therapeutic applications. Our proprietary technology, developed over 15 years of research, enables scalable production of ILCs that function like human pancreatic islet cells, offering new hope for diabetes treatment. RMS is dedicated to advancing diabetes care through cutting-edge research, product development, and clinical solutions.